miR-1469 expression in melanoma does not significantly alter susceptibility of tumor cells to apoptosis via regulation of MCL1. by Mallory J. DiVincenzo (11372420)

Subjects:

Data Sheet 1_The CML experience to elucidate the role of innate T-cells as effectors in the control of residual cancer cells and as potential targets for cancer therapy.pdf by Amandine Decroos (20222913)

“…This was particularly the case when considering iNKT cells for which surface-expression level of PD-1 even decreased relative to healthy control subjects. …”

Differentially expressed genes from pseudo-bulk analysis and the KEGG pathways of myeloid, lymphoid and fibroblast subsets. by Abishek Balakumar (20189865)

Presentation_1_Tristetraprolin limits age-related expansion of myeloid-derived suppressor cells.pptx by Kyu Hwan Kwack (5588222)

“…As TTP expression is known to decrease with age in myeloid cells, we used TTP-deficient (TTPKO) mice to model aged mice to study TTP regulation in age-related myelopoiesis. …”

Table_2_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_3_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_1_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_7_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_6_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_5_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

Table_4_A Novel Single Cell RNA-seq Analysis of Non-Myeloid Circulating Cells in Late Sepsis.xlsx by Dijoia B. Darden (9019154)

“…</p>Conclusion<p>Circulating non-myeloid cells display a unique transcriptomic pattern late after sepsis. …”

EF-24 treatment induces distinct gene expression changes in Kasumi-1 cells. by Ajeet P. Singh (22298432)

Subjects:

Image_1_Myeloid cell-derived catecholamines influence bone turnover and regeneration in mice.jpeg by Melanie R. Kuhn (13798336)

“…However, besides systemic adrenal and sympathetic catecholamine production, it is also known that myeloid cells can synthesize catecholamines, especially under inflammatory conditions. …”

Image_2_Myeloid cell-derived catecholamines influence bone turnover and regeneration in mice.jpeg by Melanie R. Kuhn (13798336)

“…However, besides systemic adrenal and sympathetic catecholamine production, it is also known that myeloid cells can synthesize catecholamines, especially under inflammatory conditions. …”

DataSheet_1_Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death.doc by Harshit Shah (9375656)

“…</p>Methods<p>We used a panel of multiple myeloid leukemia (ML) cell lines as well as leukemic patient samples and updated methodology to study auto-lysosomal compartment, lysosomal membrane permeabilization and lysosomal cell death.…”

EF-24 treatment disrupts key molecular pathways associated with cell survival, proliferation, and viability. by Ajeet P. Singh (22298432)

Subjects:

Data Sheet 1_Development of an immunodeficient mouse that allows for conditional ablation of monocytic cells.pdf by Alvin J. Hui (22555850)

Image 5_COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity.pdf by Na He (295300)

“…Our results showed that effector CD8+ T (Teff) cells were significantly downregulated while naïve CD8+ T cells or Treg cells were obviously upregulated in P210-elevated CML patients after contracting COVID-19 compared to that in P210-unchanged or decreased CML patients. …”

Image 4_COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity.pdf by Na He (295300)

“…Our results showed that effector CD8+ T (Teff) cells were significantly downregulated while naïve CD8+ T cells or Treg cells were obviously upregulated in P210-elevated CML patients after contracting COVID-19 compared to that in P210-unchanged or decreased CML patients. …”

Image 3_COVID-19 mitigates the response to TKIs in patients with CML via the inhibition of T-cell immunity.pdf by Na He (295300)

“…Our results showed that effector CD8+ T (Teff) cells were significantly downregulated while naïve CD8+ T cells or Treg cells were obviously upregulated in P210-elevated CML patients after contracting COVID-19 compared to that in P210-unchanged or decreased CML patients. …”